The Microbiome Movement – Maternal & Infant Health Summit is the only meeting uniting large pharma, biotech companies, research institutes and technology experts to harness the causality of maternal-infant microbiome and translate it into therapeutic, nutritional and preventative solutions for early life health outcomes.

New research on associations between the maternal-infant microbiome and its role in disease onset in early life is being published at an increasing rate. However, challenges remain in pinpointing disease causality, modelling interactions of highly dynamic early life and maternal microbial profiles and translating these findings into much-needed solutions for physicians, mothers and infants in need.

Join the leaders in maternal-infant microbiome research as they discuss the latest data-driven case studies and forge the collaborations you need to unlock the full potential of preventative, therapeutic and nutritional solutions in the key window of opportunity of the first 1000 days of life.

Register your interest to receive agenda and speaker updates for the 2020 program as they are announced.